Financial Neovasc Announces Dismissal of Claim brought by Edwards Lifesciences Shared by Ken Dropiewski on January 22, 2019 More in Financial: AMT Medical Secures $25 Million in Series B Funding to Revolutionize Coronary Artery Bypass Surgery April 17, 2025 Instylla Announces the Appointment of Daniel Davis to Board of Directors April 15, 2025 Windtree Therapeutics Reports Year-End 2024 Financial Results and Provides Key Business Updates April 15, 2025 Share this story Facebook Twitter LinkedIn